1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994 7;154(13):1449-1457;
2. Al-Shahi Salman R, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ. 2009 7 24 339:b2586
3. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J. Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke. 2000 11;31(11):2558-2562;
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993 7;24(7):987-993;
5. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P. CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke. 2008 11;39(11):2993-2996;
6. Delcourt C, Huang Y, Arima H, Chalmers J, Davis SM, Heeley EL, et al. INTERACT1 Investigators. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012 7;79(4):314-319;
7. Dequatre-Ponchelle N, Hénon H, Pasquini M, Rutgers MP, Bordet R, Leys D, et al. Vitamin K antagonists-associated cerebral hemorrhages: what are their characteristics? Stroke. 2013 2;44(2):350-355;
8. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2010 1;41(1):48-53;
9. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 11;141(10):745-752;
10. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007 1;68(2):116-121;
12. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004 9;63(6):1059-1064;
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke : results from the National registry of atrial fibrillation. JAMA. 2001 6;285(22):2864-2870;
14. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007 6;146(12):857-867;
15. Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006 6;37(6):1465-1470;
16. Itabashi R, Yasaka M, Kuwashiro T, Nakagaki H, Miyashita F, Naritomi H, et al. Location of acute brain hemorrhage in patients undergoing antithrombotic therapy. J Neurol Sci. 2009 5;280(1-2):87-89;
17. Jeffree RL, Gordon DH, Sivasubramaniam R, Chapman A. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage. J Clin Neurosci. 2009 6;16(7):882-885;
18. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen stroke study. Neurology. 1997 4;48(4):891-895;
19. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996 8;27(8):1304-1305;
20. Labovitz DL, Boden-Albala B, Hauser WA, Sacco RL. Lacunar infarction or deep intracerebral hemorrhage: who gets which? The northern Manhattan study. Neurology. 2007 2;68(8):606-608;
21. Lovelock CE, Molyneux AJ, Rothwell PM. Oxford vascular study. Change in incidence and etiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007 6;6(6):487-493;
23. Nilsson OG, Lindgren A, Brandt L, Saveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg. 2002 9;97(3):531-536;
24. Radberg JA, Olsson JE, Radberg CT. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke. 1991 5;22(5):571-576;
25. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004 4;164(8):880-884;
26. Toyoda K, Okada Y, Ibayashi S, Inoue T, Yasumori K, Fukui D, et al. Antithrombotic therapy and predilection for cerebellar hemorrhage. Cerebrovasc Dis. 2007 23(2-3):109-116;
27. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA. Predictors of outcome in warfarin related intracerebral hemorrhage. Arch Neurol. 2008 10;65(10):1320-1325;